Eyam Health Inc. today announced the publication of peer-reviewed research in Nature Communications describing Gemini™, a ...
HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results